Lonza Biopharmaceutical Manufacturing Facility
Sector: Manufacturing (Industrial) • Location: Vacaville, California, United States
Source: Site Selection Magazine
Lonza AG is acquiring the former Genentech plant in Vacaville, California, for $1.2 billion and plans to invest an additional $551.4 million to create one of the largest drug manufacturing operations globally. This investment aims to enhance the facility's capacity for biopharmaceutical production and support the growing demand in the biotech sector.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Under Construction |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Lonza AG is acquiring the former Genentech plant in Vacaville, California, for $1.2 billion and plans to invest an additional $551.4 million to create one of the largest drug manufacturing operations globally. This investment aims to enhance the facility's capacity for biopharmaceutical production and support the growing demand in the biotech sector. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |